Schedule 13D ownership disclosure

REATA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75615P103

Event date: 2023-08-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-220188
Form type
SC 13D/A
Filer
REATA PHARMACEUTICALS INC
CIK
CIK 1358762
Filed
Aug 24, 2023
Reporting period
Aug 23, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub